Health News Roundup: Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data; J&J talc unit faces bankruptcy judge after tactic rejected and more

The health reform is one of several key initiatives that leftist Petro, who took office just over six months ago, wants to push through to fight inequality, exclusion and poverty in the Andean country. J&J talc unit faces bankruptcy judge after tactic rejected Johnson & Johnson's subsidiary shouldering talc-related lawsuits goes before a bankruptcy judge on Tuesday for the first time since a U.S. appeals court last month nixed the company's attempt to offload the litigation into Chapter 11 proceedings.

Following is a summary of current health news briefs.

Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data

Initial public offerings by small private biotech companies are poised to stage a comeback later in 2023 as the pace of interest rate hikes slows, but tougher economic conditions will make investors more inclined to pick firms which have drugs in human trials. Globally, IPOs across all sectors nosedived last year after a blockbuster 2021, as aggressive interest rate hikes by central banks to curb inflation put an end to the era of cheap money.

J&J talc unit faces bankruptcy judge after tactic rejected

Johnson & Johnson's subsidiary shouldering talc-related lawsuits goes before a bankruptcy judge on Tuesday for the first time since a U.S. appeals court last month nixed the company's attempt to offload the litigation into Chapter 11 proceedings. A three-judge panel of the Philadelphia-based 3rd U.S. Circuit Court of Appeals on Jan. 30 ruled that the J&J subsidiary's bankruptcy case should be dismissed, finding it had no legitimate claim to Chapter 11 protection because it did not face financial distress.

Canadian premiers accept C$46-billion federal govt healthcare funding offer

Canada's provincial and territorial premiers on Monday said they will accept an additional C$46.2 billion ($34.64 billion) in healthcare funding from the federal government over the next 10 years, but warned the amount falls short of what is needed. Canadian Prime Minister Justin Trudeau met with premiers last week to hammer out a deal to fix the overburdened public healthcare system, which has been under strain due to the COVID-19 pandemic and staffing shortages.

In COVID China, a hospital bed can hinge on who you know, red packets

Steven, a financier in his 40s, tested positive for COVID-19 in Beijing at the height of China's outbreak in December and felt fine until the eighth day, when his condition worsened. His sister’s driver took him to a hospital. Barely able to walk and fighting for breath, he was told there were no beds. They drove to another; he was rejected again.

U.S. government to buy 1.5 million more Novavax COVID vaccine doses

The U.S. government has agreed to buy 1.5 million more doses of Novavax Inc COVID-19 vaccine, the company said on Monday, adding that the modified agreement includes funds for development of an updated vaccine by fall this year. Sales of the company's vaccine have been hurt by a global supply glut and waning demand, with Novavax cutting its full-year revenue forecast for the shots twice last year.

U.S. FDA declines to review Soligenix's cancer drug

Soligenix Inc said on Tuesday the U.S. Food and Drug Administration (FDA) has declined to review the drug developer's application for its cancer drug. The FDA said the company's application was not sufficiently complete to permit substantive review.

Analysis-Abortion pill lawsuit faces Texas judge who often rules for conservatives

A challenge to the U.S. government's approval of a pill used for abortions is one of the latest high-profile lawsuits to be filed by conservative advocates in a Texas court that essentially guarantees them a sympathetic judge, a one-time Christian activist. Anti-abortion groups seeking a nationwide ban on the pill sued the Biden administration in November in Amarillo, where a local order assigns 95% of federal civil cases to the lone U.S. district judge there, Matthew Kacsmaryk, an appointee of former Republican President Donald Trump.

Equatorial Guinea confirms country's first Marburg virus disease outbreak -WHO

Equatorial Guinea has confirmed its first outbreak of the Marburg virus, a highly infectious and deadly disease similar to Ebola, following the deaths of at least nine people, the World Health Organization (WHO) said on Monday. The small Central African country quarantined more than 200 people and restricted movement last week in its Kie-Ntem province after detecting an unknown hemorrhagic fever. Neighboring Cameroon also restricted movement along its border over concerns about contagion. In addition to the nine deaths, Equatorial Guinea has reported 16 suspected cases of Marburg virus with symptoms including fever, fatigue and blood-stained vomit and diarrhea, the WHO said.

Teen girls seeing 'dramatic' rise in poor mental health - U.S. CDC

Nearly three in five high school girls reported feeling sad or hopeless in 2021, representing a 60% increase over the past decade, and fared worse than boys of the same age across nearly all measures of mental health, U.S. government data showed. The data shows a "dramatic" rise in experiences of violence, poor mental health and suicide risk in teens, especially in girls, the U.S. Centers for Disease Control said on Monday.

Colombia's Petro presents controversial health reform to Congress

Colombian President Gustavo Petro on Monday presented a controversial health reform to lawmakers which his government says will improve primary care, expand access to treatment, raise healthcare worker salaries and fight corruption by eliminating private sector management of payments. The health reform is one of several key initiatives that leftist Petro, who took office just over six months ago, wants to push through to fight inequality, exclusion and poverty in the Andean country.